Tag Archives: regenerative medicine

August, 2017

28 August
FDA’s Statement on New Policy Steps to Ensure Proper Oversight of Stem Cell Therapies & Regenerative Medicine

One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments for some of humanity’s most troubling …
Share

12 December
Bayer and Versant Ventures Team up to Launch Stem Cell Therapy Company BlueRock Therapeutics with $225 Million Financing

LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 /PRNewswire/ — Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of …
Share

12 February
Amarantus’ Movement Disorder Candidate Receives Orphan Drug Designation from the FDA

Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that it has received orphan drug designation from the US FDA for Eltoprazine in the treatment of Parkinson’s disease levodopa-induced dyskinesia (PD-LID). Amarantus published positive results from a …
Share

13 April
Celgene Invests $45 Million in Stem Cell Company Mesoblast

Celgene has agreed to buy a minority stake in stem cell company Mesoblast Limited, valued at $45 million. The Australia-based company said that it has entered into an agreement with US-based Celgene Corp., under which Celgene will purchase 15.3 million ordinary shares in Mesoblast for $45 million. In return, Celgene has …
Share

31 March
Fujifilm to Acquire Stem Cell Pioneer Cellular Dynamics for $307 Million

Japan’s Fujifilm said that it will pay more than $300 million for Wisconsin-based stem cell developer Cellular Dynamics International (CDI) to strengthen its presence in the regenerative field. The companies announced that they have entered into a definitive agreement, under which Fujifilm will acquire CDI. Fujifilm aims to acquire all …
Share